Preferred Bank And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Preferred Bank (PFBC), John Bean Technologies Corporation (JBT), Koppers Holdings Koppers Holdings (KOP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Preferred Bank (PFBC)

31% sales growth and 21.21% return on equity

So, we recommend stocks like Marcus Corp (MCS Quick QuoteMCS – Free Report) , Skyline Corp. (SKY Quick QuoteSKY – Free Report) , Alaska Air Group (ALK Quick QuoteALK – Free Report) , Preferred Bank (PFBC Quick QuotePFBC – Free Report) and ICF International (ICFI Quick QuoteICFI – Free Report) , which bear low leverage and therefore can shield investors from incurring losses in times of crisis.

Preferred Bank provides various commercial banking products and services to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high net worth individuals in the United States. The company accepts checking, savings, and money market deposit accounts; fixed-rate and fixed maturity retail, and non-retail certificates of deposit; and individual retirement accounts. It also provides real estate mortgage loans that are secured by retail, industrial, office, special purpose, and residential single and multi-family properties; real estate construction loans; and commercial loans comprising lines of credit for working capital, term loans for capital expenditures, and commercial and stand-by letters of credit; and SBA loans. In addition, the company offers trade finance services, including commercial and export letters of credit, import lines of credit, documentary collections, international wire transfers, acceptances/trust receipt financing products, export financing, documentary collections, and bills purchase programs. Further, it provides various high-wealth banking services to wealthy individuals residing in the Pacific Rim area; and remote deposit capture, and online and mobile banking services. Additionally, the company offers various banking services to physicians, accountants, attorneys, business managers, and other professionals; and safe deposit boxes, account reconciliation, courier service, and cash management services to the manufacturing, service, and distribution companies. As of December 31, 2021, it had eleven full-service branch offices in Alhambra, Century City, City of Industry, Torrance, Arcadia, Irvine, Diamond Bar, Pico Rivera, Tarzana, and San Francisco; and one branch in Flushing, New York. The company was incorporated in 1991 and is headquartered in Los Angeles, California.

Earnings Per Share

As for profitability, Preferred Bank has a trailing twelve months EPS of $7.66.

PE Ratio

Preferred Bank has a trailing twelve months price to earnings ratio of 7.64. Meaning, the purchaser of the share is investing $7.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.21%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 53.6%, now sitting on 249.87M for the twelve trailing months.

2. John Bean Technologies Corporation (JBT)

8.4% sales growth and 16.2% return on equity

John Bean Technologies Corporation provides technology solutions to food and beverage industry and equipment and services to air transportation industries. The company operates through JBT FoodTech and JBT AeroTech segments. It offers poultry processing, mixing/grinding, injecting, marinating, tumbling, portioning, packaging, coating, cooking, frying, freezing, weighing, and X-ray food inspection. The company also provides processing solutions for extracting, mixing, blending, pasteurizing, sterilizing, concentrating, high pressure processing, filling, closing, sealing, and final packaging, as well as processing equipment; preservation systems; and packaging systems for poultry, beef, pork, seafood, ready-to-eat meals, fruits, vegetables, dairy, bakery, pet foods, soups, sauces, and juices. In addition, it offers automated guided vehicle systems for material movement in the manufacturing and warehouse facilities; packaging material components, such as metal clips and hanging loops; and aftermarket products, parts, and services. Further, the company provides mobile air transportation equipment, such as commercial and military cargo loading, aircraft deicing, aircraft towing, and aircraft ground power and cooling systems; and airport gate equipment for passenger boarding. Additionally, it offers airport equipment, systems, and facilities maintenance services to domestic and international airport authorities, passenger airlines, airfreight and ground handling companies, military forces, and defense contractors. The company provides its products under the DSI, Stein, THERMoFIN, GYRoCOMPACT, JSO Jet Stream, Double D, Revoband, FLoFREEZE, ADVANTEC, SuperTRAK, and READYGo trademarks; and Frigoscandia and various other brands. It markets and sells its products and solutions through direct sales force, independent distributors, and sales representatives. John Bean Technologies Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.

Earnings Per Share

As for profitability, John Bean Technologies Corporation has a trailing twelve months EPS of $4.08.

PE Ratio

John Bean Technologies Corporation has a trailing twelve months price to earnings ratio of 25.74. Meaning, the purchaser of the share is investing $25.74 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.2%.

Moving Average

John Bean Technologies Corporation’s worth is below its 50-day moving average of $105.17 and higher than its 200-day moving average of $102.80.

3. Koppers Holdings Koppers Holdings (KOP)

7.4% sales growth and 15.68% return on equity

Koppers Holdings Inc. provides treated wood products, wood treatment chemicals, and carbon compounds in the United States, Australasia, Europe, and internationally. The company operates through three segments: Railroad and Utility Products and Services (RUPS), Performance Chemicals (PC), and Carbon Materials and Chemicals (CMC). The RUPS segment procures and treats crossties, switch ties, and various types of lumber used for railroad bridges and crossings. It also provides rail joint bars to join rails together for railroads; transmission and distribution poles for electric and telephone utilities; and pilings. This segment also provides railroad services, such as engineering, design, repair, and inspection services for railroad bridges. The PC segment develops, manufactures, and markets copper-based wood preservatives, including micronized copper quaternary and micronized copper azole, micronized pigments, alkaline copper quaternary, amine copper azole, and chromated copper arsenate for decking, fencing, utility poles, construction lumber and timbers, and vineyard stakes; water-based wood preservatives and wood specialty additives; and supplies fire-retardant chemicals for pressure treatment of wood primarily in commercial construction. The CMC segment manufactures creosote for use in the treatment of wood or as a feedstock in the production of carbon black; carbon pitch, a raw material used in the production of aluminum and steel; naphthalene for use as a feedstock in the production of phthalic anhydride and as a surfactant in the production of concrete; phthalic anhydride for the production of plasticizers, polyester resins, and alkyd paints; and carbon black feedstock for use in the production of carbon black. The company serves the railroad, specialty chemical, utility, residential lumber, agriculture, aluminum, steel, rubber, and construction industries. Koppers Holdings Inc. was founded in 1988 and is headquartered in Pittsburgh, Pennsylvania.

Earnings Per Share

As for profitability, Koppers Holdings Koppers Holdings has a trailing twelve months EPS of $2.79.

PE Ratio

Koppers Holdings Koppers Holdings has a trailing twelve months price to earnings ratio of 12.04. Meaning, the purchaser of the share is investing $12.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.68%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 22% and positive 29.9% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19.1%, now sitting on 1.98B for the twelve trailing months.

4. Amphastar Pharmaceuticals (AMPH)

7.1% sales growth and 16.51% return on equity

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Earnings Per Share

As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $0.03.

PE Ratio

Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 1213.67. Meaning, the purchaser of the share is investing $1213.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.51%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 2.4% and a negative 10.6%, respectively.

Previous days news about Amphastar Pharmaceuticals(AMPH)

  • According to Zacks on Monday, 27 March, "The bottom line of Amphastar Pharmaceuticals outpaced estimates in all the last four quarters, the average surprise being 35%."

Leave a Reply

Your email address will not be published. Required fields are marked *